These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21393945)

  • 1. Topical corticosteroid abuse on the face: a prospective, multicenter study of dermatology outpatients.
    Saraswat A; Lahiri K; Chatterjee M; Barua S; Coondoo A; Mittal A; Panda S; Rajagopalan M; Sharma R; Abraham A; Verma SB; Srinivas CR
    Indian J Dermatol Venereol Leprol; 2011; 77(2):160-6. PubMed ID: 21393945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Steroid Damaged/Dependent Face (TSDF): A Study from a Tertiary Care Hospital in Eastern India.
    Pal D; Biswas P; Das S; De A; Sharma N; Ansari A
    Indian J Dermatol; 2018; 63(5):375-379. PubMed ID: 30210157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facial corticosteroid addictive dermatitis in Guiyang City, China.
    Lu H; Xiao T; Lu B; Dong D; Yu D; Wei H; Chen HD
    Clin Exp Dermatol; 2010 Aug; 35(6):618-21. PubMed ID: 20015284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Abuse of Topical Corticosteroids and Counterfeit Cosmetic Products for the Face: Prospective Demographic Study in Basrah City, Iraq.
    Jaccob AA; Yaqoub AA; Rahmani MA
    Curr Drug Saf; 2020; 15(1):25-31. PubMed ID: 31573892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticosteroid nonprescription use: a cross-sectional hospital-based study in Basrah.
    Mansour AA; Odaa AH; Wanoose HL
    Med Princ Pract; 2010; 19(3):182-7. PubMed ID: 20357499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in patients with facial steroid dermatitis before and after treatment.
    Liu ZH; Du XH
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):663-9. PubMed ID: 18331297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical Steroid Awareness and Abuse: A Prospective Study among Dermatology Outpatients.
    Nagesh TS; Akhilesh A
    Indian J Dermatol; 2016; 61(6):618-621. PubMed ID: 27904178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency.
    Aubert-Wastiaux H; Moret L; Le Rhun A; Fontenoy AM; Nguyen JM; Leux C; Misery L; Young P; Chastaing M; Danou N; Lombrail P; Boralevi F; Lacour JP; Mazereeuw-Hautier J; Stalder JF; Barbarot S
    Br J Dermatol; 2011 Oct; 165(4):808-14. PubMed ID: 21671892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misuse of topical corticosteroids: a clinical study in an Iraqi hospital.
    Al-Dhalimi MA; Aljawahiry N
    East Mediterr Health J; 2006 Nov; 12(6):847-52. PubMed ID: 17333832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Misuse of topical corticosteroids on the face: A cross-sectional study among dermatology outpatients.
    Jha AK; Sinha R; Prasad S
    Indian Dermatol Online J; 2016; 7(4):259-63. PubMed ID: 27559498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of Clinical Profile of Patients Presenting with Topical Steroid-Induced Facial Dermatosis to a Tertiary Care Hospital.
    Jain S; Mohapatra L; Mohanty P; Jena S; Behera B
    Indian Dermatol Online J; 2020; 11(2):208-211. PubMed ID: 32477980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Corticosteroid phobia in patients with atopic dermatitis].
    Jenerowicz D; Czarnecka-Operacz M; Silny W
    Wiad Lek; 2005; 58(11-12):607-15. PubMed ID: 16594469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use and abuse of topical corticosteroids in general practice].
    Pelfini C; Vignini M; Desirello G
    G Ital Dermatol Venereol; 1984; 119(2):75-88. PubMed ID: 6145668
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data.
    Balkrishnan R; Camacho FT; Pearce DJ; Kulkarni AS; Spencer L; Fleischer AB; Feldman SR
    J Drugs Dermatol; 2005; 4(6):699-706. PubMed ID: 16302555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the face and neck pattern of atopic dermatitis in Japan a special variant?
    Tada J; Yamasaki H; Toi Y; Akiyama H; Arata J
    Am J Contact Dermat; 1999 Mar; 10(1):7-11. PubMed ID: 10072348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis.
    Frankel A; Sohn A; Patel RV; Lebwohl M
    J Drugs Dermatol; 2011 Jun; 10(6):666-72. PubMed ID: 21637908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioral dermatitis: an uncommon condition?
    Hogan DJ; Epstein JD; Lane PR
    CMAJ; 1986 May; 134(9):1025-8. PubMed ID: 2938708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tinea incognito and "over-the-counter" potent topical steroids.
    Solomon BA; Glass AT; Rabbin PE
    Cutis; 1996 Oct; 58(4):295-6. PubMed ID: 8894430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.